Insmed (INSM) Misses Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $102.15 +3.59%
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +52.9%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($1.32), $0.14 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $104.44 million versus the consensus estimate of $97.68 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT
- MoveSmart Rentals Opens Toronto Branch, Expanding Its Canadian Leasing Operations
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
